SpringWorks Therapeutics Price Prediction

SWTXDelisted Stock  USD 46.99  0.00  0.00%   
The relative strength index (RSI) of SpringWorks Therapeutics' stock price is slightly above 61. This usually implies that the stock is rather overbought by investors at this time. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling SpringWorks, making its price go up or down.

Momentum 61

 Buy Extended

 
Oversold
 
Overbought
The successful prediction of SpringWorks Therapeutics' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with SpringWorks Therapeutics, which may create opportunities for some arbitrage if properly timed.
Using SpringWorks Therapeutics hype-based prediction, you can estimate the value of SpringWorks Therapeutics from the perspective of SpringWorks Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in SpringWorks Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying SpringWorks because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

SpringWorks Therapeutics after-hype prediction price

    
  USD 46.98  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of SpringWorks Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
35.4037.2751.69
Details
Naive
Forecast
LowNextHigh
42.5144.3846.24
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
46.9746.9847.00
Details

SpringWorks Therapeutics After-Hype Price Prediction Density Analysis

As far as predicting the price of SpringWorks Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in SpringWorks Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of SpringWorks Therapeutics, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

SpringWorks Therapeutics Estimiated After-Hype Price Volatility

In the context of predicting SpringWorks Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on SpringWorks Therapeutics' historical news coverage. SpringWorks Therapeutics' after-hype downside and upside margins for the prediction period are 45.11 and 48.85, respectively. We have considered SpringWorks Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
46.99
46.98
After-hype Price
48.85
Upside
SpringWorks Therapeutics is very steady at this time. Analysis and calculation of next after-hype price of SpringWorks Therapeutics is based on 3 months time horizon.

SpringWorks Therapeutics Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as SpringWorks Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading SpringWorks Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with SpringWorks Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.49 
1.87
  0.01 
  0.27 
11 Events / Month
6 Events / Month
In about 11 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
46.99
46.98
0.02 
6,233  
Notes

SpringWorks Therapeutics Hype Timeline

SpringWorks Therapeutics is at this time traded for 46.99. The entity has historical hype elasticity of -0.01, and average elasticity to hype of competition of -0.27. SpringWorks is anticipated to decline in value after the next headline, with the price expected to drop to 46.98. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.02%, whereas the daily expected return is at this time at 0.49%. The volatility of related hype on SpringWorks Therapeutics is about 337.27%, with the expected price after the next announcement by competition of 46.72. About 87.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 3.41. SpringWorks Therapeutics had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in about 11 days.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

SpringWorks Therapeutics Related Hype Analysis

Having access to credible news sources related to SpringWorks Therapeutics' direct competition is more important than ever and may enhance your ability to predict SpringWorks Therapeutics' future price movements. Getting to know how SpringWorks Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how SpringWorks Therapeutics may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
RVMDRevolution Medicines(1.07)8 per month 2.49 (0.01) 3.61 (4.27) 18.30 
BPMCBlueprint Medicines Corp 0.1 11 per month 0.61  0.17  5.43 (1.91) 26.28 
STOKStoke Therapeutics(0.34)9 per month 2.51  0.22  7.08 (2.97) 21.76 
CYTKCytokinetics 0.15 10 per month 0.00 (0.06) 4.26 (4.27) 19.11 
RLAYRelay Therapeutics 0.06 7 per month 3.74  0.10  6.55 (6.35) 16.42 
IDYAIdeaya Biosciences(0.29)10 per month 3.45  0.08  6.44 (4.71) 19.73 
KYMRKymera Therapeutics(2.31)9 per month 2.76  0.14  6.98 (4.46) 48.99 
CRNXCrinetics Pharmaceuticals(1.34)10 per month 2.93 (0.01) 4.17 (5.78) 15.72 
REPLReplimune Group 0.05 15 per month 4.89  0.14  9.93 (5.40) 34.70 

SpringWorks Therapeutics Additional Predictive Modules

Most predictive techniques to examine SpringWorks price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for SpringWorks using various technical indicators. When you analyze SpringWorks charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About SpringWorks Therapeutics Predictive Indicators

The successful prediction of SpringWorks Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as SpringWorks Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of SpringWorks Therapeutics based on analysis of SpringWorks Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to SpringWorks Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to SpringWorks Therapeutics's related companies.

Story Coverage note for SpringWorks Therapeutics

The number of cover stories for SpringWorks Therapeutics depends on current market conditions and SpringWorks Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that SpringWorks Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about SpringWorks Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

SpringWorks Therapeutics Short Properties

SpringWorks Therapeutics' future price predictability will typically decrease when SpringWorks Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of SpringWorks Therapeutics often depends not only on the future outlook of the potential SpringWorks Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. SpringWorks Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding74.1 M
Cash And Short Term Investments308 M
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Consideration for investing in SpringWorks Stock

If you are still planning to invest in SpringWorks Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the SpringWorks Therapeutics' history and understand the potential risks before investing.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Money Managers
Screen money managers from public funds and ETFs managed around the world
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals